Please assess the completion status of the following clinical trial:

Trial Title: Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~adults with neovascular age-related macula degeneration~Exclusion Criteria:~according to SmPC

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Patients with neovascular Age-Related Macula Degeneration (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).